OMRF scientists have identified a compound that could give birth to therapies for a host of eye diseases.
The pair of four-year, $1.75 million NIH Research Project Grants, or R01s, will support separate projects.
The discovery could lead to new therapeutic approaches to a wide range of illnesses, including asthma, inflammatory bowel disease and psoriasis.
OMRF’s Courtney Griffin succeeds OCASCR’s founding scientific director, Paul Kincade, who is retiring.
The most common method of screening for colon cancer is a colonoscopy. However, certain cancer-causing polyps can be easily missed during an examination.
OMRF researchers found that, in laboratory mice, a particular white blood cell seems to play a key role in MS.